Filing Flows › Comparisons › VYCO vs CNSY
Vycor Medical vs Cerenome: VYCO and CNSY compared
Vycor Medical is the larger company: $418K of revenue in its latest quarter (Q2 2026) against $411K for Cerenome (Q2 2026). Vycor Medical is growing faster (-16% against -70% a year earlier).
Where the money goes: VYCO and CNSY
Vycor Medical (VYCO) · Q2 2026
Vycor Medical, Q2 2026: revenue $418K (-16% year over year), operating margin 1.6%, net loss $22K, operating cash flow −$5K. The chart follows the revenue to costs, profit and cash.
Cerenome (CNSY) · Q2 2026
Cerenome, Q2 2026: revenue $411K (-70% year over year), net loss $9.0M, operating cash flow −$7.1M. The chart follows the revenue to costs, profit and cash.
| Vycor Medical (VYCO) | Cerenome (CNSY) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $418K | $411K |
| Revenue growth, Y/Y | -16% | -70% |
| Operating margin | 1.6% | n/m |
| Net earnings | −$22K | −$9.0M |
| Net margin | -5.3% | — |
| Operating cash flow | −$5K | −$7.1M |
Where the revenue comes from
Vycor Medical
- Vycor Medical Inc: $401K (96%)
- NovaVision Inc: $17K (4%)
Questions
Which is bigger, Vycor Medical or Cerenome?
Vycor Medical is the larger company: $418K of revenue in its latest quarter (Q2 2026) against $411K for Cerenome (Q2 2026).
Is Vycor Medical or Cerenome growing faster?
Vycor Medical is growing faster (-16% against -70% a year earlier).
More: Vycor Medical earnings · how Vycor Medical makes money · Cerenome earnings · how Cerenome makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 14, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.